Cogent Biosciences, Inc. UMRX
No live quote for UMRX yet.
Valuation
P/E -0.2×
FY 2018 5y median -0.5× FY 2019
P/S 0.2×
FY 2018 5y median 1.5× FY 2019
P/B 0.2×
FY 2018 5y median 0.3× FY 2019
P/FCF -0.1×
FY 2018 5y median -0.5× FY 2019
EV/EBITDA 0.8×
FY 2018 5y median 0.8× FY 2019
EV/Sales -1.2×
FY 2018 5y median -2.0× FY 2019
FCF Yield -757.1%
FY 2018 5y median -438.8% FY 2019
Profitability
Gross Margin 100.0%
FY 2018 5y median 100.0% FY 2019
Operating Margin -143.0%
FY 2018 5y median -256.5% FY 2019
Net Margin -141.5%
FY 2018 5y median -248.1% FY 2019
ROE -100.2%
FY 2018 5y median -78.8% FY 2019
ROIC -89.0%
FY 2018 5y median -65.9% FY 2019
ROA -64.4%
FY 2018 5y median -52.3% FY 2019
Growth (YoY)
Revenue 131.1%
FY 2018 FY 2019
Operating Income 10.6%
FY 2018 FY 2019
EPS (diluted) 24.7%
FY 2018 FY 2019
Free Cash Flow -25.8%
FY 2018 FY 2019
Financial Health
Current Ratio 3.1×
FY 2018 5y median 3.2× FY 2019
Quick Ratio 3.1×
FY 2018 5y median 3.2× FY 2019
Debt / Equity 0.2×
FY 2018 5y median 0.1× FY 2019
Net Debt / EBITDA 1.0×
FY 2018 5y median 1.4× FY 2019
Interest Coverage 0.0×
FY 2018 5y median 0.0× FY 2019
Dividends
Dividend Yield 0.0%
FY 2018 5y median 0.0% FY 2019
Payout Ratio 0.0%
FY 2018 5y median 0.0% FY 2019
Annual · latest fiscal year ends 2019-12-31